Home page > Quality health systems and services > Medicines, health technology and health information

5/02/2013

Launch of EU Rapid Alert platform for human tissues and cells

On 1 February 2013 the European Commission launched a new Rapid Alert platform for Tissues and Cells (RATC) to exchange urgent information relating to human tissues or cells transferred across borders. In addition to tracking quality and safety defects in tissues and cells, the RATC can be used to raise the alarm on illegal and fraudulent activities, as well as on developing epidemiological situations (e.g. disease outbreaks) which may have cross-border implications. The Commission (...)
27/05/2010

MEPs vote to support action on organ donation in the EU

MEPs have voted in favour of the report by Miroslav Mikolasik MEP (Slovakia, EPP), establishing quality and safety standards for transplantation of human organs in the EU. In December 2008, the European Commission adopted two mechanisms to address these issues: an Action Plan enhancing coordination and cooperation between Member States, and a Directive containing the basic safety and quality procedures for transplantation. The report of Mr Miroslav Mikolasik on the Directive was adopted (...)
29/04/2010

2nd Pan-European Conference on Haemoglobinopathies

A pan-European conference, hosted by EPHA member Thalassaemia International Federation (TIF), has called for closer collaboration between all stakeholders to secure optimal treatment and quality of life for patients living with haemoglobin disorders in Europe. The conclusion of the 2nd Pan-European Conference on Haemoglobinopathies, held on 13–14 March 2010 in Berlin, was that closer collaboration between medical and patient communities, as well as national and EU-level (...)
5/09/2008

New e-MSc Course in Haemoglobinopathies

University College London (UCL) in collaboration with Thalassaemia International Federation is launching the first academic course for health professionals specialising in haemoglobinopathies. This unique e-learning course offers health professionals from around the world the opportunity to pursue a specialist qualification from a leading university with minimum disruption to professional and personal lives. The course will provide a thorough understanding of the holistic care and all (...)
5/09/2008

Thalassaemia International Federation (TIF) to hold two conferences in Singapore

11th International Conference on Thalassaemia and Haemoglobinopathies & 13th International TIF Conference for Thalassaemia Patients and Parents 8–11 October 2008 Singapore This major biennial event is a highlight on the thalassaemia community calendar, attracting health professionals, patients and their families from around the world for five intensive days of informative presentations on the latest advances in the treatment, cure and prevention of thalassaemia and other (...)
21/07/2006

A new report on consent and confidentiality in genetic practices

The Royal College of Physicians and the British Society of Human Genetics have joined forces to publish a new report on Consent and confidentiality in genetic practices. It aims to develop guidance on: genetic testing ans sharing information, obtaining consent prior to genetic tests, regulations for giving and sharing genetic information with family members and between professionals, genetic investigations on stored human tissues. It comes timely with the highly sensitive debates (...)
24/05/2005

Commission report on the challenges of biometrics

The Commission has published the report ’Biometrics at the Frontiers: Assessing the Impact on Society’. The study assesses how biometric technologies, like fingerprinting and iris and face recognition, will impact on our daily lives. The report is published in the context of the new EU requirement for biometric passports, visas and residence permits from 2006. Biometrics are often thought of only in terms of security and border controls, but the report makes the claim that (...)
18/11/2004

First standard for Human Genetic Test approved

The first international standard for a human genetic test was approved by the World Health Organisation (WHO) Expert Committee on Biological Standardisation (ECSB) on November 17 2004. The test, one of the most frequently carried out, is for Factor V Leiden, a particular genetic mutation creating a predisposition to thrombosis - a potentially life threatening blood disorder. The standard provides reference material enabling all laboratories worldwide to carry out the test consistently and (...)
26/04/2004

MEPs contamined by 76 different toxic chemicals

WWF and The Co-operative Bank took and analysed the blood of 47 people from all over Europe in December 2003. These included 39 Members of the European Parliament, 4 Observers from accession countries, 1 former MEP and 3 WWF staff, representing 17 countries in Europe. The results released on 21 April 2004 are unacceptable. It reveal that every person is contaminated with a cocktail of persistent, bio-accumulative and toxic chemicals including chemicals from each of the 5 groups of (...)
2/03/2006

European Council approves new legislation on human tissues and cells

The European Council adopted on 3rd March 2004 a proposal for a directive setting out harmonised safety and quality standards for dealing with human tissues and cells. The Council adopted all the amendments proposed by the European Parliament in second reading. The dossier was amended in second reading on the rules for voluntary donation, traceability and types of source material used for transplantation. Standards of quality and safety of human tissues and cells UPDATE: On February (...)

0 | 10